| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
Tokyo (TSE) : 4502 Tokyo, Japan website |
Life Science | 37,921 | 24 | 18 | 6 |
|
Tokyo (TSE) : 4503 Tokyo, Japan website |
Life Science | 15,828 | 16 | 14 | 2 |
|
|
Daiichi Sankyo
Tokyo (TSE) : 4568 Tokyo, Japan website |
Life Science | 15,612 | 8 | 4 | 4 |
|
|
Takara Bio
Tokyo (TSE) : 4974 Kusatsu, Japan website |
Life Science | 373 | 3 | 3 | - |
|
|
Shionogi
Tokyo (TSE) : 4507 Osaka, Japan website |
Life Science | 3,628 | 5 | 3 | 2 |
|
|
Santen Pharmaceutical
Tokyo (TSE) : 4536 Osaka, Japan website |
Life Science | 2,483 | 4 | 3 | 1 |
|
|
ReproCELL
Tokyo (TSE) : 4978 Yokohama, Japan website |
Life Science | 25 | 3 | 3 | - |
|
|
MEDINET Co.
Tokyo (TSE) : 2370 Yokohama, Japan website |
Life Science | 6 | 2 | 2 | - |
|
|
Toho Holdings
Tokyo (TSE) : 9812 Hakodate, Japan website |
Life Science | 200 | 2 | 2 | - |
|
|
AnGes
Tokyo (TSE) : 4563 Ibaraki, Japan website |
Life Science | 5 | 1 | 1 | - |
|
|
Shin Nippon Biomedical Laboratories
Tokyo (TSE) : 2395 Kagoshima, Japan website |
Life Science | 268 | 2 | 1 | 1 |
|
|
Zeria Pharmaceutical
Tokyo (TSE) : 4559 Tokyo, Japan website |
Life Science | 723 | 1 | 1 | - |
|
|
Nxera Pharma
Tokyo (TSE) : 4565 Minato, Japan website |
Life Science | 239 | 1 | 1 | - |
|
|
JCR Pharmaceuticals
Tokyo (TSE) : 4552 Ashiya, Japan website |
Life Science | 274 | 1 | 1 | - |
|
|
Kaken Pharmaceutical
Tokyo (TSE) : 4521 Tokyo, Japan website |
Life Science | 778 | 1 | 1 | - |
|
|
Sumitomo Pharma
Tokyo (TSE) : 4506 Osaka, Japan website |
Life Science | 3,301 | 2 | 1 | 1 |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.